Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevalence and Incidence of Antibodies Against SARS-CoV-2 in Children Measured for One Year in Belgium: a Sero-epidemiological Prospective Cohort Study

NCT04613817 is registered in ClinicalTrials.gov with Sciensano as lead sponsor.

NCT NCT04613817
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04613817 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevalence and Incidence of Antibodies Against SARS-CoV-2 in Children Measured for One Year in Belgium: a Sero-epidemiological Prospective Cohort Study
Lead sponsor
Sciensano
Phase
Observational
Overall status
Completed
Start date
December 3, 2020
Completion date
December 31, 2021
Enrollment
2,103 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, sars-cov infection, sars-cov-2